When a young woman died in 1951, few could have predicted the impact her ‘immortal’ legacy would have on the world of modern medicine – least of all, her surviving family. Join us as we trace the rise of HeLa and one family’s fight for recognition.
The evolution of active patient inclusion in trials
NIHR’s Professor Melanie Davies sheds light on the evolving role of patients and how engaging with individuals before and during their healthcare pathway can lead to successful recruitment and retention in clinical trials.
“Any day now” is today: Pfizer pioneers individual data sharing
After long campaigns, patients in the US are starting to have the right to access clinical notes about them, with Pfizer leading the charge in individual data sharing for US clinical trial participants.
Understanding how patient experience and input needs to be captured, contextualised, and applied to the process of medicine innovation is critical. Lumanity’s Susan Daniels discusses combining patient and healthcare provider engagement strategies.
For many spin-outs and start-ups in the pharmaceutical space, a key step in getting their science into patients is teaming up with a larger pharmaceutical company. But how can both parties protect themselves and their intellectual property?
‘What If?’ Poetry as a platform for the patient voice
The power of the written word has long been heralded for its ability to move hearts and minds. For National Poetry Day, Sanofi tapped into this phenomenon with a poetry competition for patients. Nicole Raleigh reports from the event.
Calculus’s Liz Klein: Investing in a changing landscape
In the ever-evolving realm of healthcare and pharmaceuticals, the intricate dance between innovation and investment shapes the trajectory of research and innovation, as Calculus Capital’s Liz Klein explains.